September 30, 2025
Best Mutual Funds To Buy 2018
Mutual Funds have reported a spectacular performance in 2017 with mammoth gains of up to 83%. The astonishing part is that even the model portfolios prepared by eminent stock wizards have not beaten this record
Mutual Funds have reported a spectacular performance in 2017 with mammoth gains of up to 83%. The astonishing part is that the mutual funds have surpassed the returns given by model portfolios prepared by eminent stock wizards




R Srinivasan of SBI Mutual Fund lives upto reputation of ‘Rockstar Fund Manager

Best Mutual Funds For 2018

In a piece written as long back as in 2012, I described R Srinivasan, the fund manager of SBI Mutual Fund, as a “rockstar fund manager”.

I conferred this prestigious title upon Srinivasan owing to his spectacular track record of churning out returns that have not only beaten the benchmarks by a wide margin but also his peers.

Srinivasan has again lived up to his reputation by getting his SBI Small and Mid Cap Direct to deliver a magnificent return of 83.1% for the year ended 31st December 2017.

This sensational news was revealed by moneybhaskar.

The performance of the mutual funds in other categories was also revealed.

It is notable that several mutual funds have effortlessly clocked a return in excess of 50%.

Small and mid-cap fund Return
SBI Small and Mid Cap Direct (G) 83.1%
L & T Emerging Business Fund DP (G) 69.6%
IDFC Sterling Equity Direct (G) 66.0%
Large cap fund Return
IDFC Equity Direct (G) 61.5%
JM Core 11 Fund Direct (G) 50.6%
DHFL Large Cap – DP (G)     47.2%
Balanced Fund Return
Principal Balanced – Direct (G) 40.2%
Baroda Pioneer Balanced – Direct 33.9%
Reliance ASF Balanced – Direct (G) 33.5%
Diversified Equity Return
HDFC Small Cap Fund Direct (G) 64.7%
Sundaram Value Fund Sr I – Direct (G) 62.3%
Reliance Capital Builder -II-Sr-B DP (G) 57.9%
Thematic infrastructure Return
L & T Infrastructure – Direct (G) 65.0%
IDFC Infrastructure – Direct (G)     63.6%
Reliance Diversified Power – Direct (G) 63.7%
Tax Saving Fund (ELSS) Return
BOI Tax Advantage – Direct (G)     61.0%
IDFC Tax Advantage – Direct (G) 56.9%
Principal Tax Saving – Direct     52.3%
Banking and finance sector fund Return
ABSL Bank & Finance Sector – DP (G) 54.9%
Invesco India Banking – Dir (G) 52.6%
ICICI Pru Banking & Finance Service – Direct (G) 51.2%
FMCG Sector Fund Return
SBI FMCG Fund – Direct (G) 60.3%
ICICI Pru Fund – Direct (G)     41.2%

(There are only two funds in this sector.)

Technology Sector Fund Return
ABSL New Millennium – Direct (G) 24.5%
ICICI Prudential Technologies – Direct (G) 21.4%
Tata Digital India Fund – Direct (G) 22.1%
Other sector fund Return
Tata India Consumer Fund – Direct (G) 80.8%
Can Robeco FORCE – Direct (G) 47.3%
ABSL Manufacturing Equity – DP (G) 44.8%
Index fund Return
Reliance ETF Junior BeES 48.8%
IDBI Nifty Junior Index – Direct (G) 48.1%
ICICI Pru NN50IF – Direct (G) 48.7%

However, the Pharma and Healthcare Sector Funds spoilt the show by delivering sub-par returns.

Pharma & Healthcare Sector Fund Return
Reliance Pharma Fund – Direct (G) 6.2%
UTI Pharma Health – Direct (G) 5.6%
Reliance Pharma Fund (G)     5.3%



Prima facie, it appears that Pharma sector may continue to report disappointing returns owing to the Damocles sword of the USFDA inspections, warning letters and banning.

In fact, Basant Maheshwari has expressed the opinion that Pharma has seen its best days and is unlikely to repeat its past glory. It is better to look at other sectors for multibagger gains.

Portfolio and sectoral allocation of SBI Small and Mid Cap Direct

We have to peep into the portfolio of the SBI Small and Mid Cap Direct to see what stocks R Srinivasan bought that contributed to the spectacular performance.

The top ten holdings as of 30th November 2017 are as follows:

Equity Sector Value
(Rs cr)
Asset %
Westlife Dev Banking/Finance 57.53 6.48
Relaxo Footwear Cons NonDurable 42.48 4.78
Kirloskar Ind Engineering 41.79 4.71
Hawkins Cooker Cons Durable 39.27 4.42
Elgi Equipments Engineering 37.53 4.23
Orient Refract Cement 37.50 4.22
Tamil Newsprint Manufacturing 36.71 4.13
Camlin Fine Chemicals 35.74 4.02
Hatsun Agro Food & Beverage 34.75 3.91
Techno Electric Engineering 33.86 3.81

The sectoral allocation is as follows:

Industry Ratio
CONSUMER GOODS 24.82
INDUSTRIAL MANUFACTURING 14.16
SERVICES 12.25
CHEMICALS 11.99
CONSTRUCTION 6.99
FINANCIAL SERVICES 6.31
TEXTILES 4.59
PAPER 4.13
AUTOMOBILE 2.94
MEDIA AND ENTERTAINMENT 2.68

Click here to view full portfolio and sectoral breakdown

Model Portfolios recommended by Gurus lag behind

The spectacular performance of the mutual funds is creditable because it outperforms the gains given eminent stock wizards.

According to my calculations, the average return from the stocks recommended by the Gurus of Outlook Business was only 36% which is average.

The Gurus of CNBC TV18 fared somewhat better with an average return of 50%.

Of course, some specific stocks recommended by the gurus delivered multibagger returns of upto 200%+.

Novice investors throng mutual funds

Some novice investors are doing the sensible thing by investing their savings in mutual funds instead of coming to Dalal Street and foraging for stocks in the bushes.


In fact, according to moneybhaskar, as of November 2017, the asset size of mutual funds has increased to Rs 22.73 lakh crore while the number of new accounts/ folios rose to 6.49 million. Out of this, the number of new accounts (folios) of equity, tax saving and balanced funds increased to 5.30 crore.




Best Mutual Funds For 2018

Now let us home in on the best mutual funds to buy for 2018.

Manoj Nagpal, an authority on mutual funds, offered valuable recommendations on the best mutual funds to buy in an interview with the charming Sumaira Abidi.

In addition, three leading mutual fund experts, being Amol Joshi of PlanRupee Investor Service, Suresh Sadagopan of Ladder7 Financial Advisors and Vijai Mantri of Buckfast Financial Advisory Services have recommended the following mutual funds as offering the best bang for the buck in an article in Bloomberg Quint.

Top Mutual Fund Picks
   
Amol Joshi of PlanRupee Investment Services
 
Largecap Reliance Top 200
Multicap Motilal Oswal MOSt Focused Multicap 35
Mid & smallcap Franklin India Prima Fund
Balanced ICICI Pru Balanced
ELSS Aditya Birla SL Tax Relief 96
   
Suresh Sadagopan of Ladder7 Financial Advisories
   
Largecap Birla SL Frontline Equity Fund
Multicap Motital Oswal Most Focussed 35 Multicap Fund
Mid/smallcap Mirae Asset Emerging Bluechip Fund
Balanced HDFC Balanced Fund
ELSS Birla SL Tax Relief 96
   
Vijai Mantri of Buckfast Financial Advisory Services
   
Largecap Mirae Assets India Opp Fund
Multicap Invesco Contra Fund
Mid/smallcap HDFC Small Cap
Balanced Principal Balance Fund
ELSS IDFC

No doubt, the selection of mutual funds by the experts is stellar and is likely to shower hefty gains upon investors in 2018 as well.








5 thoughts on “Top Mutual Funds Delight With 83% Return, Beat Returns Of Eminent Stock Wizards

  1. If you are not an expert,for small cap and mid cap stocks go for small and mid cap mutual funds. I also invest around 25 to 30% of my portfolio in small cap/mid cap mutual funds through Sip and directly invest in only large cap stocks. In large cap and bigger mid cap stocks most of information is in public domain, but in small cap one has to dig deep(if you are not speculating), which only a full time expert can do.In my view if any body last year could not get 40 % plus return in his small and mid cap portfolio, mutual funds are best place for them. As in good mutual funds they would have got it. No recommendation, just for discussion.

  2. Pharma and Healthcare Mutual Funds have not done well because they have ignored many high growth great pharma stocks like Lincoln Pharma which has delivered 60% returns in just the last 3 months, 30% returns in last calendar year, 230% since 3 years and 421% since past 5 years. Not even a single Mutual fund has bought Lincoln Pharma till date despite the fact that the company is giving such good returns and showing great sales and profits every quarter and is now even starting an NBFC company like how Piramal Enterprises had started and are also close to getting USFDA approval. Lincoln Pharma stock reached Rs.250 today, 1st Jan 2018, up from Rs.145 on 11th Aug 2017 and is now well on its way to move above Rs.300 and more than that, but Pharma Mutual funds are ignoring such stocks and hence delivering poor returns.

  3. SBI Small and Midcap from day one is a class apart. He needs to feel happy, who got stuck in the fund when it was open in the Daiwa days and later.

Leave a Reply

Your email address will not be published. Required fields are marked *